IB
IBO
IMPACT BIOMEDICAL INC.
$0.5850
+4.46%
$63.1M
No data for this timeframe.
Vol
Market Cap$63.1M
Cap SizeMicro Cap
Inst. Holders13 funds
Inst. Value$1.3M
Inst. Activity1 buys / 0 sells
Insider Activity0B / 3S
Insider Net $-$57.8K
SEC Reports2
Press Releases1
Recent Activity
Apr 29, 2026
SEC
DSS, Inc., a major stockholder, filed Form 144 to sell 31,939,778 shares of Impact Biomedical Inc., valued at approximat
144 — Impact 8/10
Mar 31, 2026
SEC
Analysis based on filing metadata only — document content was unavailable. This insider trading cluster involves recent
CLUSTER — Impact 4/10
Mar 27, 2026
Insider
Macko Todd D sold 43,400 shares
Chief Financial Officer @ $0.5615 ($24.4K)
Mar 25, 2026
Insider
Macko Todd D sold 1,600 shares
Chief Financial Officer @ $0.6008 ($961.28)
Mar 23, 2026
Insider
Grady Jason sold 50,000 shares
Director @ $0.6501 ($32.5K)
Inst.
STATE STREET CORP — DOUBLED
607,897 shares ($364.7K)
Inst.
VANGUARD GROUP INC — DOUBLED
814,885 shares ($411.5K)
Apr 3, 2026
Press
Impact BioMedical (IBO) disclosed that its 2025 audit opinion includes a 'going concern' qualification, signaling substa
Impact 8/10
Latest Reports
BEARISH
144
8/10
DSS, Inc., a major stockholder, filed Form 144 to sell 31,939,778 shares of Impact Biomedical Inc., valued at approximat
Apr 29, 2026
BEARISH
Press
8/10
Impact BioMedical (IBO) disclosed that its 2025 audit opinion includes a 'going concern' qualification, signaling substa
Apr 3, 2026
BEARISH
CLUSTER
4/10
Analysis based on filing metadata only — document content was unavailable. This insider trading cluster involves recent
Mar 31, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| ROYAL BANK OF CANADA | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $424.9K | — |
| STATE STREET CORP | $364.7K | DOUBLED |
| VANGUARD FIDUCIARY TRUST CO | $351.1K | — |
| BlackRock, Inc. | $156.0K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 27, 2026 | Macko Todd | SELL | $24.4K |
| Mar 25, 2026 | Macko Todd | SELL | $961.28 |
| Mar 23, 2026 | Grady Jason | SELL | $32.5K |
13 institutional holders with $1.3M total value (2,241,041 shares) as of 2026-Q1. Top holders: ROYAL, VANGUARD, STATE. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | ROYAL BANK OF CANADA | 32 | $0.00 | 0.0% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 708,168 | $424.9K | 31.6% | — |
| 3 | STATE STREET CORP | 607,897 | $364.7K | 27.1% | DOUBLED +5053.0% |
| 4 | VANGUARD FIDUCIARY TRUST CO | 585,198 | $351.1K | 26.1% | — |
| 5 | BlackRock, Inc. | 259,946 | $156.0K | 11.6% | — |
| 6 | TWO SIGMA INVESTMENTS, LP | 37,427 | $22.5K | 1.7% | ADD +26.4% |
| 7 | Vanguard Global Advisers, LLC | 32,201 | $19.3K | 1.4% | — |
| 8 | MORGAN STANLEY | 9,274 | $5.6K | 0.4% | — |
| 9 | CITIGROUP INC | 353 | $212.00 | 0.0% | — |
| 10 | FMR LLC | 290 | $174.00 | 0.0% | — |
| 11 | WELLS FARGO & COMPANY/MN | 224 | $134.00 | 0.0% | DOUBLED +772.4% |
| 12 | CWM, LLC | 28 | $17.00 | 0.0% | DOUBLED +2700.0% |
| 13 | DANSKE BANK A/S | 3 | $2.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| STATE STREET CORP | DOUBLED | 11,797 | 607,897 | +5053.0% | $364.7K | 2026-Q1 |
| VANGUARD GROUP INC | DOUBLED | 102,905 | 814,885 | +691.9% | $411.5K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 31,500 | 39,827 | +26.4% | $20.1K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 168 | 924 | +450.0% | $467.00 | 2025-Q4 |
| CWM, LLC | DOUBLED | 1 | 28 | +2700.0% | — | 2025-Q3 |
| VANGUARD GROUP INC | DOUBLED | 32,437 | 102,905 | +217.2% | $68.4K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | ADD | 22,700 | 31,500 | +38.8% | $20.9K | 2025-Q3 |
| UBS Group AG | TRIM | 39,725 | 20,088 | -49.4% | $13.4K | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 29 | 253 | +772.4% | $168.00 | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 80 | 168 | +110.0% | $111.00 | 2025-Q3 |
| UBS Group AG | DOUBLED | 16,167 | 39,725 | +145.7% | $25.7K | 2025-Q2 |
| VANGUARD GROUP INC | TRIM | 126,446 | 32,437 | -74.3% | $21.0K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 1,029 | 29 | -97.2% | $19.00 | 2025-Q2 |
| HRT FINANCIAL LP | NEAR_EXIT | 68,158 | 10,326 | -84.8% | $6.00 | 2025-Q2 |
| UBS Group AG | DOUBLED | 4,252 | 16,167 | +280.2% | $14.1K | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 29 | 1,029 | +3448.3% | $895.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 3 | 4,252 | +141633.3% | $6.2K | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 2,596 | 17 | -99.3% | $24.00 | 2024-Q4 |
2 unique insiders with 3 transactions. Net insider value: -$57.8K ($0.00 bought, $57.8K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Macko Todd D | Chief Financial Officer | SELL | 43,400 | $0.5615 | $24.4K |
| Mar 25, 2026 | Macko Todd D | Chief Financial Officer | SELL | 1,600 | $0.6008 | $961.28 |
| Mar 23, 2026 | Grady Jason | Director | SELL | 50,000 | $0.6501 | $32.5K |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 0 neutral. Avg impact: 6.0/10.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Apr 3, 2026
activist
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
<p>HOUSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO) announced that its annual report(10-K) for the fiscal yea
Mar 9, 2026
short_interest
FTD: IBO — 1,311,412 shares ($0.9M) failed to deliver
Settlement: 20260309, Price: $0.67, FTD Value: $878,646.04, IMPACT BIOMEDICAL INC COM NEW
Mar 6, 2026
short_interest
FTD: IBO — 2,851,096 shares ($1.8M) failed to deliver
Settlement: 20260306, Price: $0.64, FTD Value: $1,824,701.44, IMPACT BIOMEDICAL INC COM NEW
Mar 5, 2026
short_interest
FTD: IBO — 1,612,866 shares ($0.7M) failed to deliver
Settlement: 20260305, Price: $0.41, FTD Value: $661,275.06, IMPACT BIOMEDICAL INC COM NEW